Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Sanz MA, Montesinos P. Sanz MA, et al. Among authors: montesinos p. Thromb Res. 2010 Apr;125 Suppl 2:S51-4. doi: 10.1016/S0049-3848(10)70013-X. Thromb Res. 2010. PMID: 20434005 Review.
Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA. Sanz J, et al. Among authors: montesinos p. Bone Marrow Transplant. 2007 May;39(9):555-61. doi: 10.1038/sj.bmt.1705641. Epub 2007 Mar 12. Bone Marrow Transplant. 2007. PMID: 17351645
Multivariate analysis shows that HSCT from unrelated donors (P=0.02) and the development of chronic extensive graft-versus-host disease (GVHD) (P=0.0004) were the only independent factors associated with AIHA. ...
Multivariate analysis shows that HSCT from unrelated donors (P=0.02) and the development of chronic extensive graft-versus-host disea …
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
Adès L, Sanz MA, Chevret S, Montesinos P, Chevallier P, Raffoux E, Vellenga E, Guerci A, Pigneux A, Huguet F, Rayon C, Stoppa AM, de la Serna J, Cahn JY, Meyer-Monard S, Pabst T, Thomas X, de Botton S, Parody R, Bergua J, Lamy T, Vekhoff A, Negri S, Ifrah N, Dombret H, Ferrant A, Bron D, Degos L, Fenaux P. Adès L, et al. Among authors: montesinos p. Blood. 2008 Feb 1;111(3):1078-84. doi: 10.1182/blood-2007-07-099978. Epub 2007 Nov 1. Blood. 2008. PMID: 17975017
In patients with white blood cell (WBC) count less than 10 x 10(9)/L, complete remission (CR) rates were similar, but 3-year cumulative incidence of relapse (CIR) was significantly lower in LPA 99 trial: 4.2% versus 14.3% (P = .03), although 3-year survival was similar in …
In patients with white blood cell (WBC) count less than 10 x 10(9)/L, complete remission (CR) rates were similar, but 3-year cumulative inci …
Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T. Rickles FR, et al. Among authors: montesinos p. Thromb Res. 2007;120 Suppl 2:S99-106. doi: 10.1016/S0049-3848(07)70137-8. Thromb Res. 2007. PMID: 18023721
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J, Jarque I, Sanz G, Sanz MA. Montesinos P, et al. Haematologica. 2008 Jan;93(1):67-74. doi: 10.3324/haematol.11575. Haematologica. 2008. PMID: 18166787
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
de la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, Esteve J, Bergua JM, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA. de la Serna J, et al. Among authors: montesinos p. Blood. 2008 Apr 1;111(7):3395-402. doi: 10.1182/blood-2007-07-100669. Epub 2008 Jan 14. Blood. 2008. PMID: 18195095 Clinical Trial.
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
Sanz MA, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, Bergua JM, León A, Negri S, González M, Rivas C, Esteve J, Milone G, González JD, Amutio E, Brunet S, García-Laraña J, Colomer D, Calasanz MJ, Chillón C, Barragán E, Bolufer P, Lowenberg B. Sanz MA, et al. Among authors: montesinos p. Blood. 2008 Oct 15;112(8):3130-4. doi: 10.1182/blood-2008-05-159632. Epub 2008 Jul 29. Blood. 2008. PMID: 18664623
These results compare favorably with those obtained in the previous LPA96 study (P = .019 and P = .04, respectively). This updated analysis confirms the high antileukemic efficacy, low toxicity, and high degree of compliance of a risk-adapted strategy combining ATRA …
These results compare favorably with those obtained in the previous LPA96 study (P = .019 and P = .04, respectively). This upd …
Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA. Lo-Coco F, et al. Among authors: montesinos p. Semin Oncol. 2008 Aug;35(4):401-9. doi: 10.1053/j.seminoncol.2008.04.010. Semin Oncol. 2008. PMID: 18692690
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA. Montesinos P, et al. Blood. 2009 Jan 22;113(4):775-83. doi: 10.1182/blood-2008-07-168617. Epub 2008 Oct 22. Blood. 2009. PMID: 18945964 Clinical Trial.
Patients developing severe DS showed a reduced 7-year relapse-free survival in the LPA96 trial (60% vs 85%, P = .003), but this difference was not apparent in the LPA99 trial (86% vs 88%)....
Patients developing severe DS showed a reduced 7-year relapse-free survival in the LPA96 trial (60% vs 85%, P = .003), but this diffe …
Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
Moscardó F, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF. Moscardó F, et al. Among authors: montesinos p. Haematologica. 2009 Jun;94(6):827-32. doi: 10.3324/haematol.2008.000935. Haematologica. 2009. PMID: 19483157 Free PMC article.
The incidence of primary graft failure was 67% for patients with less than 65% donor chimerism at day +14 as compared to only 2% for those with more than 65% donor chimerism (p<0.001). Patients with mixed chimerism also had a lower cumulative incidence of platelet engra …
The incidence of primary graft failure was 67% for patients with less than 65% donor chimerism at day +14 as compared to only 2% for those w …
211 results
Jump to page
Feedback